ROVALCYTE 50 mg/ml, powder for oral solution bottle, 12 g
Active ingredients: Valganciclovir hydrochloride, Valganciclovir
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral solutionbottle, 12 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROVALCYTE 50 mg/ml, poudre pour solution buvable
- Pharmaceutical form
- poudre pour solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun avec fermeture de sécurité enfant de 12 g de poudre avec adaptateur(s) pour flacon polyéthylène basse densité (PEBD) avec 2 seringue(s) pour administration orale polypropylène polyéthylène
- Marketing authorisation holder
- CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Jun 2009
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60626471CIP73867337CIP133400938673371Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VALGANCICLOVIRpoudre | 50 mg · 1 ml de solution reconstituée | FT |
| CHLORHYDRATE DE VALGANCICLOVIRpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.